Caris Life Sciences Inc
(CAI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,078 | 14,393 | 14,492 | 28,535 | 8,433 |
| Receivables | 45,435 | 40,370 | 33,365 | 40,907 | 35,233 |
| Income taxes - deferred | 1,968 | 1,931 | 1,669 | 1,924 | 1,777 |
| Other current assets | 6,343 | 5,312 | 10,776 | 6,671 | 4,834 |
| TOTAL | $74,903 | $68,651 | $63,379 | $80,991 | $53,428 |
| Non-Current Assets | |||||
| PPE Net | 843,942 | 533,322 | 299,775 | 311,026 | 243,074 |
| Investments And Advances | 31,591 | 7,886 | 5,844 | 14,003 | 6,356 |
| Intangibles | 2,333 | 3,593 | 5,085 | 6,608 | 56,241 |
| Other Non-Current Assets | 599 | 0 | 0 | 0 | 0 |
| TOTAL | $878,465 | $544,801 | $310,704 | $331,637 | $305,671 |
| Total Assets | $953,368 | $613,452 | $374,083 | $412,628 | $359,099 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,764 | 24,800 | 800 | N/A | N/A |
| Accounts payable and accrued liabilities | 36,950 | 113,791 | 25,975 | 32,434 | 49,581 |
| Accrued Expenses | 5,761 | 5,408 | 3,638 | 3,747 | 1,411 |
| TOTAL | $79,053 | $154,161 | $38,451 | $45,237 | $54,767 |
| Non-Current Liabilities | |||||
| Long Term Debt | 575,014 | 220,800 | 161,500 | 208,200 | 147,600 |
| Deferred Revenues | 6,786 | 5,724 | 4,225 | 4,542 | 3,744 |
| Other Non-Current Liabilities | -625 | 181 | 0 | 0 | 0 |
| TOTAL | $625,579 | $261,617 | $206,534 | $253,601 | $173,184 |
| Total Liabilities | $704,632 | $415,778 | $244,985 | $298,838 | $227,951 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 19,295 | 19,295 | 17,917 | 17,921 | 17,145 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 105,232 | 55,043 | 26,660 | 13,104 | 40,057 |
| Other shareholders' equity | 15,319 | 15,565 | -1,248 | -2,022 | 101 |
| TOTAL | $248,736 | $197,674 | $129,098 | $113,790 | $131,148 |
| Total Liabilities And Equity | $953,368 | $613,452 | $374,083 | $412,628 | $359,099 |